Conestoga Capital Advisors LLC Has $42.94 Million Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Conestoga Capital Advisors LLC lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 25.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,248 shares of the biotechnology company’s stock after selling 24,205 shares during the quarter. Conestoga Capital Advisors LLC owned 0.09% of Axon Enterprise worth $42,938,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter valued at about $200,000. Massachusetts Financial Services Co. MA bought a new position in Axon Enterprise in the third quarter valued at about $120,553,000. International Assets Investment Management LLC acquired a new position in Axon Enterprise in the 3rd quarter valued at approximately $871,860,000. Westfield Capital Management Co. LP grew its position in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its position in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares during the period. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on AXON. TD Cowen started coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Finally, Needham & Company LLC lifted their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $524.85.

Insiders Place Their Bets

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 50,545 shares of company stock valued at $30,721,337 in the last ninety days. Insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Down 2.5 %

Shares of Axon Enterprise stock opened at $636.00 on Monday. Axon Enterprise, Inc. has a 52-week low of $252.20 and a 52-week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company’s 50-day simple moving average is $619.63 and its 200-day simple moving average is $483.68. The firm has a market cap of $48.50 billion, a price-to-earnings ratio of 164.34, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.